1. Home
  2. PULM vs PASW Comparison

PULM vs PASW Comparison

Compare PULM & PASW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PULM
  • PASW
  • Stock Information
  • Founded
  • PULM 2003
  • PASW 2021
  • Country
  • PULM United States
  • PASW Hong Kong
  • Employees
  • PULM N/A
  • PASW N/A
  • Industry
  • PULM Biotechnology: Pharmaceutical Preparations
  • PASW Apparel
  • Sector
  • PULM Health Care
  • PASW Consumer Discretionary
  • Exchange
  • PULM Nasdaq
  • PASW Nasdaq
  • Market Cap
  • PULM 18.3M
  • PASW 15.9M
  • IPO Year
  • PULM N/A
  • PASW N/A
  • Fundamental
  • Price
  • PULM $4.87
  • PASW $0.73
  • Analyst Decision
  • PULM
  • PASW
  • Analyst Count
  • PULM 0
  • PASW 0
  • Target Price
  • PULM N/A
  • PASW N/A
  • AVG Volume (30 Days)
  • PULM 17.6K
  • PASW 394.3K
  • Earning Date
  • PULM 10-16-2025
  • PASW 11-15-2025
  • Dividend Yield
  • PULM N/A
  • PASW N/A
  • EPS Growth
  • PULM N/A
  • PASW N/A
  • EPS
  • PULM N/A
  • PASW N/A
  • Revenue
  • PULM $3,000.00
  • PASW $8,286,193.00
  • Revenue This Year
  • PULM N/A
  • PASW N/A
  • Revenue Next Year
  • PULM $134.88
  • PASW N/A
  • P/E Ratio
  • PULM N/A
  • PASW N/A
  • Revenue Growth
  • PULM N/A
  • PASW N/A
  • 52 Week Low
  • PULM $2.00
  • PASW $0.69
  • 52 Week High
  • PULM $10.40
  • PASW $5.40
  • Technical
  • Relative Strength Index (RSI)
  • PULM 50.82
  • PASW N/A
  • Support Level
  • PULM $4.55
  • PASW N/A
  • Resistance Level
  • PULM $4.95
  • PASW N/A
  • Average True Range (ATR)
  • PULM 0.21
  • PASW 0.00
  • MACD
  • PULM 0.02
  • PASW 0.00
  • Stochastic Oscillator
  • PULM 46.72
  • PASW 0.00

About PULM Pulmatrix Inc.

Pulmatrix Inc is a biopharmaceutical company that has focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented dry powder delivery technology, iSPERSE. Its pipeline of clinical assets includes PUR3100 for the treatment of acute migraine, PUR1800 for the treatment of acute exacerbations of chronic obstructive pulmonary disease (AECOPD), and PUR1900 for the treatment of ABPA in patients with asthma and in patients with cystic fibrosis (CF).

About PASW Ping An Biomedical Co. Ltd. Ordinary Shares

Ping An Biomedical Co Ltd formerly Majestic Ideal Holdings Ltd is a Cayman Islands-based holding company, conducting operations through its PRC subsidiary, NewBrand. The group is a provider of SCM services in the apparel industry, offering solutions for a broad range of yarn products, textiles, and finished garments. Its service offerings encompass every key aspect of the supply chain of textile products, such as market trend analysis, product design and development, raw material sourcing, production and quality control, and logistics management. The group has two reportable segments, yarns and finished garments. The majority of its revenue is generated from the sale of yarns, including pure cashmere and cashmere-mix yarn, merino wool, cotton, and fancy yarn.

Share on Social Networks: